Avalo Therapeutics (AVTX) Inventory Average (2018 - 2023)
Avalo Therapeutics posted quarterly Inventory Average of $18500.0 for Q2 2023, down 22.92% year-on-year from $24000.0 in Q2 2022, and down 5.13% on a QoQ basis from $19500.0 in Q1 2023.
Avalo Therapeutics (AVTX) has 6 years of Inventory Average data on file, last reported at $18500.0 in Q2 2023.
- For the quarter ending Q2 2023, Inventory Average fell 22.92% year-over-year to $18500.0; the trailing twelve-month figure through Jun 2023 stood at $18500.0 (down 22.92% YoY), and the FY2022 full-year result was $29000.0, up 41.46% from the prior year.
- Inventory Average for Q2 2023 stood at $18500.0, down from $19500.0 in the prior quarter.
- Across five years, Inventory Average topped out at $682452.5 in Q1 2019 and bottomed at $6030.0 in Q4 2020.
- The 5-year median for Inventory Average is $20250.0 (2022), against an average of $80425.1.
- The widest annual swing landed in 2020, when Inventory Average slumped 97.24%; it then surged 347.76% in 2021.
- A 5-year view of Inventory Average shows it stood at $211800.5 in 2019, then tumbled by 97.15% to $6030.0 in 2020, then soared by 347.76% to $27000.0 in 2021, then slipped by 22.22% to $21000.0 in 2022, then retreated by 11.9% to $18500.0 in 2023.
- The last three Inventory Average figures came in at $18500.0 (Q2 2023), $19500.0 (Q1 2023), and $21000.0 (Q4 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 30.59 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.73 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 3.15 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 83.37 Mn |
| 10 | Avalo Therapeutics | 317.29 Mn | 317.29 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 18,500.00 |
| Mar 31, 2023 | 19,500.00 |
| Dec 31, 2022 | 21,000.00 |
| Sep 30, 2022 | 22,500.00 |
| Jun 30, 2022 | 24,000.00 |
| Mar 31, 2022 | 31,500.00 |
| Dec 31, 2021 | 27,000.00 |
| Sep 30, 2021 | 18,000.00 |
| Dec 31, 2020 | 6,030.00 |
| Sep 30, 2020 | 10,628.00 |
| Jun 30, 2020 | 14,236.00 |
| Mar 31, 2020 | 18,805.00 |
| Dec 31, 2019 | 211,800.50 |
| Mar 31, 2019 | 682,452.50 |
| Dec 31, 2018 | 691,196.00 |
| Sep 30, 2018 | 1.30 Mn |
| Jun 30, 2018 | 2.49 Mn |
| Mar 31, 2018 | 1.91 Mn |